TAILIEUCHUNG - Pharmaceutical Substances Syntheses, Patents, Applications - Part 179

Pharmaceutical Substances Syntheses, Patents, Applications - Part 179. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Raloxifene hydrochloride R 1781 1. AICIj CH2CI2 2. HjC SH 3. HCI THF Raloxifene hydrochloride VII VI 1. DMF 2. HjC SH AICIj CH2CI2 Raloxifene hydrochloride C0CI2 phosgene 6-methoxy-2- 4-methoxy-phenyl -benzo b thiophene-3-corbonyl chloride BCIj 1 2-dichloroethane 0 C -------------------- Roloxifene hydrochloride phenyl 2-piperidiho-ethyl ether hydrochloride alternative regiospecific synthesis of I deoxyanisoin 2-methyl- 2-propone-thiol DC tert-butyl 4 4 -di- methoxy-a-stilbenyl sulfide X 1782 R Raloxifene hydrochloride H-jC-CO-O-OH CHjCOOH toluene tert-butyl 4 4 -di- methoxy-a-stilbenyl sulfoxide XI Tos-OH. toluene Znl2 1 2-dichloroethane IX ------------------------ . zinc iodide tert-butyl 4-methoxyb enzyl sulfide XII THF p-onisoldehyde Reference s a b Jones . et al. J. Med. Chem. JMCMAR 27 1057 1984 . EP 62 504 Lilly Co. appl. USA-prior. . Vicenzi . et al. Org. Process Res. Dev. OPRDFK 3 56-59 1999 . a US 4 418 068 Lilly Co. USA-prior. . aa EP 699 672 E. Lilly Co. appl. USA-prior. . b EP 693 488 Lilly Co. appl. USA-prior. . US 4 380 635 Lilly Co. USA-prior. . c EP 738 725 E. Lilly Co. appl. USA-prior. . d WO 9 734 888 E. Lilly Co. appl. USA-prior. . e WO 9 640 691 E. Lilly Co. appl. USA-prior. . WO 9 640 693 E. Lilly Co. appl. USA-prior. . WO 9 640 677 E. Lilly Co. appl. USA-prior. . WO9 640 676 E. Lilly Co. appl. USA-prior. . US 5 512 701 E. Lilly Co. USA-prior. . preparation of an amorphous form and formulation WO 9 808 513 E. Lilly Co. appl. USA-prior. . preparation of glucopyranosides metabolites as antihyper libpidemics EP 683 170 E. Lilly Co. appl. USA-prior. . treatment of hormone dependent cancers EP 62 503 E. Lilly Co. appl. USA-prior. . method for lowering .

Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.